본문 바로가기
KERD
논문KCI 등재

Alcohol use disorder and liver transplant: new perspectives and critical issues

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Alcoholic liver disease is a consolidated indication for liver transplantation, but many unsolved issues can be highlighted. Patients with alcohol use disorder develop peculiar comorbidities that can become contraindications for transplantation. Moreover, a number of social and psychological patterns should be evaluated to select candidates with a low risk of alcohol relapse and adequate post-transplant adherence. In this context, the 6-month rule is too rigid to be widely applied. A short period of abstinence (1 to 3 months) is useful to estimate recovery of liver function and, possibly to avoid transplant. Cardiovascular disorders and extra-hepatic malignancies represent the main clinical issues after transplant. Patients transplanted due to alcoholic disease are a major risk for other liver diseases. Severe corticosteroid-resistant alcoholic acute hepatitis is a debated indication for transplant. However, available data indicate that well-selected patients have excellent post-transplant outcomes. Behavioral therapy, continued psychological support and a multidisciplinary team are essential to achieve and maintain complete alcohol abstinence during the transplant process. Alcoholic liver disease is an excellent indication for a liver transplant but patients with alcohol use disorder deserve a personalized approach and dedicated resources.

Abstract

Alcoholic liver disease is a consolidated indication for liver transplantation, but many unsolved issues can be highlighted. Patients with alcohol use disorder develop peculiar comorbidities that can become contraindications for transplantation. Moreover, a number of social and psychological patterns should be evaluated to select candidates with a low risk of alcohol relapse and adequate post-transplant adherence. In this context, the 6-month rule is too rigid to be widely applied. A short period of abstinence (1 to 3 months) is useful to estimate recovery of liver function and, possibly to avoid transplant. Cardiovascular disorders and extra-hepatic malignancies represent the main clinical issues after transplant. Patients transplanted due to alcoholic disease are a major risk for other liver diseases. Severe corticosteroid-resistant alcoholic acute hepatitis is a debated indication for transplant. However, available data indicate that well-selected patients have excellent post-transplant outcomes. Behavioral therapy, continued psychological support and a multidisciplinary team are essential to achieve and maintain complete alcohol abstinence during the transplant process. Alcoholic liver disease is an excellent indication for a liver transplant but patients with alcohol use disorder deserve a personalized approach and dedicated resources.

참고문헌 (135)

  1. European Association for the Study of the Liver, "EASL clinical practice guidelines: management of alcoholrelated liver disease", J Hepatol, 69, pp.154~181 (2018)
  2. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders DSM-5™" (2013), American Psychiatric Publishing
  3. Rehm J, "Alcohol use disorders in primary health care : what do we know and where do we go", Alcohol Alcohol, 51, pp.422~427 (2016)
  4. "International Statistical Classification of Diseases and Related Health Problems" (2011)[URL]
  5. Rehm J, "The relationship between different dimensions of alcohol use and the burden of disease-an update", Addiction, 112, pp.968~1001 (2017)
  6. Department of Health and Human Services, "Dietary Guidelines for Americans 2015-2020" (2017), Skyhorse Publishing
  7. Global Status Report on Noncommunicable Diseases 2014, "World Health Organization", WHO, ~ (2014)
  8. Bell G, "Alcohol and death certification: a survey of current practice and attitudes", Br Med J(Clin Res Ed), 295, pp.95~ (1987)
  9. Public Health Successes and Missed Opportunities: Trends in Alcohol Consumption and Attributable Mortality in the WHO European Region, 1990-2014, "Shield KD", World Health Organization, Regional Office for Europe, ~ (2016)
  10. Rehm J, "Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders", Lancet, 373, pp.2223~2233 (2009)
  11. GBD 2013 Risk Factors Collaborators, "Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 386, pp.2287~2323 (2015)
  12. Adolescent Obesity and Related Behaviours: Trends and Inequalities in the WHO European Region, 2002-2014, "World Health Organization", World Health Organization, Regional Office for Europe, ~ (2017)
  13. Sassi F, "Tackling Harmful Alcohol Use: Economics and Public Health Policy" (2015), OECD Publishing
  14. World Health Organization, "Food-Based Dietary Guidelines in the WHO European Region", WHO Regional Office for Europe, ~ (2003)
  15. Rehm J, "Alcohol as a risk factor for liver cirrhosis : a systematic review and metaanalysis", Drug Alcohol Rev, 29, pp.437~445 (2010)
  16. Mathurin P, "Trends in the management and burden of alcoholic liver disease", J Hepatol, 62, pp.S38~S46 (2015)
  17. Gao B, "Alcoholic liver disease : pathogenesis and new therapeutic targets", Gastroenterology, 141, pp.1572~1585 (2011)
  18. Wong RJ, "Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States", Gastroenterology, 148, pp.547~555 (2015)
  19. Burra P, "Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry)", Am J Transplant, 10, pp.138~148 (2010)
  20. Merion RM, "The survival benefit of liver transplantation", Am J Transplant, 5, pp.307~313 (2005)
  21. Addolorato G, "Liver transplantation for alcoholic liver disease", Transplantation, 100, pp.981~987 (2016)
  22. Gallegos-Orozco JF, "Alcoholic liver disease and liver transplantation", Clin Liver Dis, 20, pp.521~534 (2016)
  23. European Association for the Study of the Liver, "EASL clinical practice guidelines : liver transplantation", J Hepatol, 64, pp.433~485 (2016)
  24. European Association for the Study of Liver, "EASL clinical practical guidelines : management of alcoholic liver disease", J Hepatol, 57, pp.399~420 (2012)
  25. Donckier V, "Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy", J Hepatol, 60, pp.866~871 (2014)
  26. Marroni CA, "Management of alcohol recurrence before and after liver transplantation", Clin Res Hepatol Gastroenterol, 39(Suppl 1), pp.S109~S114 (2015)
  27. De Gottardi A, "A simple score for predicting alcohol relapse after liver transplantation : results from 387 patients over 15 years", Arch Intern Med, 167, pp.1183~1188 (2007)
  28. Pfitzmann R, "Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease", Liver Transpl, 13, pp.197~205 (2007)
  29. Burra P, "Liver transplantation in alcoholic patients", Transpl Int, 18, pp.491~498 (2005)
  30. "Liver advisory group alcohol guidelines" (2008)[URL]
  31. Kotlyar DS, "A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease", Am J Gastroenterol, 103, pp.734~743 (2008)
  32. Gaglio PJ Jr, "Complications in patients with alcohol-associated liver disease who undergo liver transplantation", Clin Liver Dis, 16, pp.865~875 (2012)
  33. Kim WR, "OPTN", SRTR 2016annual data report : liver, 2018, pp.18(Suppl 1), 172~253
  34. Singal AK, "Nutrition in alcoholic liver disease", Clin Liver Dis, 16, pp.805~826 (2012)
  35. Jepsen P, "The clinical course of alcoholic cirrhosis: development of comorbid diseases", Liver Int, 36, pp.1696~1703 (2016)
  36. Purnak T, "Liver disease and malnutrition", Best Pract Res Clin Gastroenterol, 27, pp.619~629 (2013)
  37. Singal AK, "Evolving frequency and outcomes of liver transplantation based on etiology of liver disease", Transplantation, 95, pp.755~760 (2013)
  38. Berlakovich GA, "Challenges in transplantation for alcoholic liver disease", World J Gastroenterol, 20, pp.8033~8039 (2014)
  39. Kasper DL, "Harrison’s Manual of Medicine" (2016), McGraw Hill
  40. Kortas DY, "Mallory-Weiss tear : predisposing factors and predictors of a complicated course", Am J Gastroenterol, 96, pp.2863~2865 (2001)
  41. Szabo G, "Effect of ethanol on inflammatory responses : implications for pancreatitis", Pancreatology, 7, pp.115~123 (2007)
  42. Donnadieu-Rigole H, "Effects of alcohol withdrawal on monocyte subset defects in chronic alcohol users", J Leukoc Biol, 100, pp.1191~1199 (2016)
  43. Hassan AN, "Patients with alcohol use disorder co-occurring with depression and anxiety symptoms: diagnostic and treatment initiation recommendations", J Clin Psychiatry, 79, pp.17ac11999~ (2018)
  44. Martin P, "Evaluation for liver transplantation in adults: 2013practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation", Hepatology, 59, pp.1144~1165 (2014)
  45. Ursic-Bedoya J, "Liver transplantation for alcoholic liver disease : lessons learned and unresolved issues", World J Gastroenterol, 21, pp.10994~11002 (2015)
  46. Dasarathy S, "Nutrition and alcoholic liver disease : effects of alcoholism on nutrition, effects of nutrition on alcoholic liver disease, and nutritional therapies for alcoholic liver disease", Clin Liver Dis, 20, pp.535~550 (2016)
  47. McClain CJ, "Alcoholic liver disease and malnutrition", Alcohol Clin Exp Res, 35, pp.815~820 (2011)
  48. Tsien C, "Post-liver transplantation sarcopenia in cirrhosis : a prospective evaluation", J Gastroenterol Hepatol, 29, pp.1250~1257 (2014)
  49. Dasarathy S, "Posttransplant sarcopenia : an underrecognized early consequence of liver transplantation", Dig Dis Sci, 58, pp.3103~3111 (2013)
  50. Mazurak VC, "Nutrition and the transplant candidate", Liver Transpl, 23, pp.1451~1464 (2017)
  51. Caly WR, "Different degrees of malnutrition and immunological alterations according to the aetiology of cirrhosis : a prospective and sequential study", Nutr J, 2, pp.10~ (2003)
  52. Testino G, "Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation : an Italian position statement", World J Gastroenterol, 20, pp.14642~14651 (2014)
  53. Dutkowski P, "Challenges to liver transplantation and strategies to improve outcomes", Gastroenterology, 148, pp.307~323 (2015)
  54. Rustad JK, "Risk factors for alcohol relapse following orthotopic liver transplantation : a systematic review", Psychosomatics, 56, pp.21~35 (2015)
  55. Gramenzi A, "Authors’ reply:comment to “liver transplantation for patients with alcoholic liver disease: an open question”", Dig Liver Dis, 45, pp.81~ (2013)
  56. Chuncharunee L, "Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease : a systematic review and meta-analysis", BMC Gastroenterol, 19, pp.150~ (2019)
  57. Egawa H, "Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan", Liver Transpl, 20, pp.298~310 (2014)
  58. Kelly M, "Predictors of relapse to harmful alcohol after orthotopic liver transplantation", Alcohol Alcohol, 41, pp.278~283 (2006)
  59. Karim Z, "Predictors of relapse to significant alcohol drinking after liver transplantation", Can J Gastroenterol, 24, pp.245~250 (2010)
  60. Pageaux GP, "Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism", Gut, 45, pp.421~426 (1999)
  61. Osorio RW, "Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease", Hepatology, 20, pp.105~110 (1994)
  62. Hartl J, "Strong predictors for alcohol recidivism after liver transplantation : nonacceptance of the alcohol problem and abstinence of <3months", Scand J Gastroenterol, 46, pp.1257~1266 (2011)
  63. Askgaard G, "Predictors of heavy drinking after liver transplantation for alcoholic liver disease in Denmark(1990-2013) : a nationwide study with competing risks analyses", Scand J Gastroenterol, 51, pp.225~235 (2016)
  64. Rodrigue JR, "Substance abuse treatment and its association with relapse to alcohol use after liver transplantation", Liver Transpl, 19, pp.1387~1395 (2013)
  65. Im GY, "Liver transplantation for alcoholic hepatitis", J Hepatol, 70, pp.328~334 (2019)
  66. Dew MA, "Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs", Liver Transpl, 14, pp.159~172 (2008)
  67. Leong J, "Evaluation and selection of the patient with alcoholic liver disease for liver transplant", Clin Liver Dis, 16, pp.851~863 (2012)
  68. "Minimal criteria for liver transplantation 2003" (2020)[URL]
  69. Testino G, "Liver transplantation in alcoholic patients", Alcohol Clin Exp Res, 38, pp.1800~1802 (2014)
  70. Faure S, "Excessive alcohol consumption after liver transplantation impacts on longterm survival, whatever the primary indication", J Hepatol, 57, pp.306~312 (2012)
  71. Vaillant GE, "A 60-year follow-up of alcoholic men", Addiction, 98, pp.1043~1051 (2003)
  72. Kodali S, "Alcohol relapse after liver transplantation for alcoholic cirrhosis-impact on liver graft and patient survival : a meta-analysis", Alcohol Alcohol, 53, pp.166~172 (2018)
  73. Cuadrado A, "Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease", Liver Transpl, 11, pp.420~426 (2005)
  74. Rice JP, "Should length of sobriety be a major determinant in liver transplant selection", Curr Opin Organ Transplant, 18, pp.259~264 (2013)
  75. Marroni CA, "Liver transplantation and alcoholic liver disease : History, controversies, and considerations", World J Gastroenterol, 24, pp.2785~2805 (2018)
  76. Litten RZ, "Alcohol biomarkers in applied settings : recent advances and future research opportunities", Alcohol Clin Exp Res, 34, pp.955~967 (2010)
  77. Burra P, "Neoplastic disease after liver transplantation : focus on de novo neoplasms", World J Gastroenterol, 21, pp.8753~8768 (2015)
  78. Madhwal S, "Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies", Liver Transpl, 18, pp.1140~1146 (2012)
  79. Desai S, "Cardiovascular risk factors following orthotopic liver transplantation : predisposing factors, incidence and management", Liver Int, 30, pp.948~957 (2010)
  80. Hong JC, "Immunosuppressive agents in organ transplantation : past, present, and future", Semin Nephrol, 20, pp.108~125 (2000)
  81. Canzanello VJ, "Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506)", Liver Transpl Surg, 3, pp.1~9 (1997)
  82. Di Maira T, "Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients", Liver Transpl, 21, pp.812~822 (2015)
  83. Watt KD, "Metabolic syndrome and liver transplantation : a review and guide to management", J Hepatol, 53, pp.199~206 (2010)
  84. Lucey MR, "Long-term management of the successful adult liver transplant : 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation", Liver Transpl, 19, pp.3~26 (2013)
  85. Albeldawi M, "Cumulative risk of cardiovascular events after orthotopic liver transplantation", Liver Transpl, 18, pp.370~375 (2012)
  86. Watt KD, "Long-term probability of and mortality from de novo malignancy after liver transplantation", Gastroenterology, 137, pp.2010~2017 (2009)
  87. Chandok N, "Burden of de novo malignancy in the liver transplant recipient", Liver Transpl, 18, pp.1277~1289 (2012)
  88. Sanchez W, "Will all liver transplantation patients eventually die from cancer?", J Hepatol, 44, pp.13~18 (2006)
  89. Watt KD, "Evolution of causes and risk factors for mortality post-liver transplant : results of the NIDDK long-term follow-up study", Am J Transplant, 10, pp.1420~1427 (2010)
  90. Schrem H, "Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection", Liver Transpl, 19, pp.1252~1261 (2013)
  91. Verran DJ, "Nature and outcomes of the increased incidence of colorectal malignancy after liver transplantation in Australasia", Med J Aust, 199, pp.610~612 (2013)
  92. Baccarani U, "De novo tumors are a major cause of late mortality after orthotopic liver transplantation", Transplant Proc, 41, pp.1303~1305 (2009)
  93. Soulillou JP, "Controlling the incidence of infection and malignancy by modifying immunosuppression", Transplantation, 72, pp.S89~S93 (2001)
  94. Dantal J, "Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence : randomised comparison of two cyclosporin regimens", Lancet, 351, pp.623~628 (1998)
  95. Mithoefer AB, "Risk factors associated with the development of skin cancer after liver transplantation", Liver Transpl, 8, pp.939~944 (2002)
  96. Saigal S, "Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation", Liver Transpl, 8, pp.482~487 (2002)
  97. Cogliano VJ, "Preventable exposures associated with human cancers", J Natl Cancer Inst, 103, pp.1827~1839 (2011)
  98. Benlloch S, "De novo internal neoplasms after liver transplantation : increased risk and aggressive behavior in recent years", Am J Transplant, 4, pp.596~604 (2004)
  99. Jimenez C, "Incidence and risk factors for the development of lung tumors after liver transplantation", Transpl Int, 20, pp.57~63 (2007)
  100. Jain A, "Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus", Transplantation, 70, pp.1335~1342 (2000)
  101. Bellamy CO, "Liver transplantation for alcoholic cirrhosis : long term followup and impact of disease recurrence", Transplantation, 72, pp.619~626 (2001)
  102. Castelli E, "Indicators of genetic damage in alcoholics : reversibility after alcohol abstinence", Hepatogastroenterology, 46, pp.1664~1668 (1999)
  103. Franceschi S, "Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy", Cancer Res, 50, pp.6502~6507 (1990)
  104. Lucey MR, "Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit", Hepatology, 50, pp.400~406 (2009)
  105. Testino G, "Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis:position paper of the Italian Society on Alcohol (SIA)", Dig Liver Dis, 52, pp.21~32 (2020)
  106. Singal AK, "Liver transplantation in alcoholic liver disease current status and controversies", World J Gastroenterol, 19, pp.5953~5963 (2013)
  107. "Evolution of LTs in Europe" (2020)[URL]
  108. Shen NT, "Systematic review with meta-analysis on transplantation for alcohol-related liver disease : very low evidence of improved outcomes", World J Gastroenterol, 25, pp.1628~1639 (2019)
  109. Mathurin P, "Early liver transplantation for severe alcoholic hepatitis", N Engl J Med, 365, pp.1790~1800 (2011)
  110. Im GY, "Early liver transplantation for severe alcoholic hepatitis in the United States : a single-center experience", Am J Transplant, 16, pp.841~849 (2016)
  111. Gish RG, "Liver transplantation for patients with alcoholism and end-stage liver disease", Am J Gastroenterol, 88, pp.1337~1342 (1993)
  112. Di Martino V, "Impact of liver transplantation(LT)on alcohol consumption(AC)in patients with Pugh B cirrhosis : a randomized study", J Hepatol, 40(Suppl 1), pp.44~ (2004)
  113. Lucey MR, "Alcoholic hepatitis", N Engl J Med, 360, pp.2758~2769 (2009)
  114. Nguyen TA, "The worsening profile of alcoholic hepatitis in the United States", Alcohol Clin Exp Res, 40, pp.1295~1303 (2016)
  115. Crabb DW, "Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis : recommendation from the NIAAA alcoholic hepatitis consortia", Gastroenterology, 150, pp.785~790 (2016)
  116. Yang AL, "Epidemiology of alcohol-related liver and pancreatic disease in the United States", Arch Intern Med, 168, pp.649~656 (2008)
  117. Thursz MR, "Prednisolone or pentoxifylline for alcoholic hepatitis", N Engl J Med, 372, pp.1619~1628 (2015)
  118. Louvet A, "The Lille model : a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids", Hepatology, 45, pp.1348~1354 (2007)
  119. Papastergiou V, "Nine scoring models for short-term mortality in alcoholic hepatitis : cross-validation in a biopsy-proven cohort", Aliment Pharmacol Ther, 39, pp.721~732 (2014)
  120. Mathurin P, "Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis : meta-analysis of individual patient data", Gut, 60, pp.255~260 (2011)
  121. Singal AK, "Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis : exploratory analysis from the UNOS database", Hepatology, 55, pp.1398~1405 (2012)
  122. Al-Saeedi M, "Meta-analysis of patient survival and rate of alcohol relapse in livertransplanted patients for acute alcoholic hepatitis", Langenbecks Arch Surg, 403, pp.825~836 (2018)
  123. Schlagintweit HE, "A review of behavioral alcohol interventions for transplant candidates and recipients with alcohol-related liver disease", Am J Transplant, 19, pp.2678~2685 (2019)
  124. Caputo F, "Diagnosis and treatment of alcohol use disorder in patients with endstage alcoholic liver disease", Hepatology, 70, pp.410~417 (2019)
  125. Weinrieb RM, "Alcoholism treatment after liver transplantation : lessons learned from a clinical trial that failed", Psychosomatics, 42, pp.110~116 (2001)
  126. Attilia ML, "The multidisciplinary support in preventing alcohol relapse after liver transplantation : a single-center experience", Clin Transplant, 32, pp.e13243~ (2018)
  127. Erim Y, "Feasibility and acceptability of an alcohol addiction therapy integrated in a transplant center for patients awaiting liver transplantation", Alcohol Alcohol, 51, pp.40~46 (2016)
  128. Addolorato G, "Liver transplantation in alcoholic patients : impact of an alcohol addiction unit within a liver transplant center", Alcohol Clin Exp Res, 37, pp.1601~1608 (2013)
  129. Hendershot CS, "Relapse prevention for addictive behaviors", Subst Abuse Treat Prev Policy, 6, pp.17~ (2011)
  130. Witkiewitz K, "Relapse prevention for alcohol and drug problems : that was Zen, this is Tao", Am Psychol, 59, pp.224~235 (2004)
  131. Hettema J, "Motivational interviewing", Annu Rev Clin Psychol, 1, pp.91~111 (2005)
  132. Weinrieb RM, "Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates", J Addict Dis, 20, pp.105~119 (2001)
  133. Zhu J, "Contemporary policies regarding alcohol and marijuana use among liver transplant programs in the United States", Transplantation, 102, pp.433~439 (2018)
  134. Masson S, "An ‘alcohol contract’ has no significant effect on return to drinking after liver transplantation for alcoholic liver disease", Transpl Int, 27, pp.475~481 (2014)
  135. Golfieri L, "Impact of psychosocial status on liver transplant process", Ann Hepatol, 18, pp.804~809 (2019)

관련 논문AI추천

이 간행물의 다른 논문 (35건)